Autism Spectrum Disorders (ASD) Treatment Market Size, Share, Growth, Analysis and Forecast 2023-2030

The global ASD treatment market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. According to the World Health Organization (WHO), ASDs are a diverse group of conditions. They are characterized by some degree of difficulty with social interaction and communication. Other characteristics are atypical patterns of activities and behaviors, such as difficulty with the transition from one activity to another, a focus on details, and unusual reactions to sensations. In 2023, the Centers for Disease Control and Prevention (CDC) reported that approximately 1 in 36 children in the US is diagnosed with an ASD, according to 2020 data. The growing number of cases diagnosed with autism spectrum disorder along with growing awareness about the disease is the major factor driving the growth of the market across the globe.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/autism-spectrum-disorders-asd-treatment-market

 

Various organizations are working in collaboration with the government and private players to propagate awareness related to the disease which is anticipated to propel the ASD market. For instance, in July 2021, the Government published its autism strategy, which sets out how it plans to support autistic adults and children in England over the next five years. Under the strategy, the government plans to invest $12.4 million into finding new ways to reduce diagnosis waiting times for children and young people. Also, invest $3.0 million to improve the quality of adult diagnostic and post-diagnostic pathways and diagnosis waiting times. Furthermore, the government plans to introduce awareness programs by investing $21.9 million to prevent autistic people from falling into mental health crises and provide $24.8 million to local authorities to help people in mental health hospitals back into the community.

Market Coverage

  • The market number available for – 2022-2030
  • Base year- 2022
  • Forecast period- 2023-2030
  • Segment Covered- 

o             By Treatment Type

o             By Application

o             By Distribution Channel

  • Regions Covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

  • Competitive Landscape- including Johnson & Johnson Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Bristol-Myers Squibb, and others, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Autism Spectrum Disorders (ASD) Treatment Market Report Segment

By Treatment Type

  • Antipsychotic Drugs
  • Selective Serotonin Reuptake Inhibitors
  • Stimulants
  • Sleep Medications
  • Others

By Application

  • Autistic Disorder
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

A full report of Autism Spectrum Disorders (ASD) Treatment Market available @ https://www.omrglobal.com/industry-reports/autism-spectrum-disorders-asd-treatment-market

 

Autism Spectrum Disorders (ASD) Treatment Market Report Segment by Region

 

North America          

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

 

  • Axial Therapeutics Inc.
  • Bristol Myers Squibb Co.
  • Curemark, LLC
  • Eli Lilly and Company
  • Hoffman-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Q BioMed Inc.

Reasons to Buying From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

 

 

Media Contact:

 

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research